Free shipping on all orders over $ 500

Gardiquimod diTFA 

Cat. No. M27867
Gardiquimod diTFA  Structure
Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Gardiquimod diTFA, an imidazoquinoline analog, is a TLR7/8 agonist. Gardiquimod diTFA could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod diTFA specifically activates TLR7 when used at concentrations below 10 μM.

Chemical Information
Molecular Weight 541.44
Formula C21H25F6N5O5
CAS Number 1159840-61-5
Form Solid
Solubility (25°C) DMSO 50 mg/mL (ultrasonic)
Water 25 mg/mL (ultrasonic)
Storage 4°C, dry, sealed
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Deepak Kumar Goyal, et al. Infect Genet Evol. Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis

[2] Suqian Guo, et al. J Biochem Mol Toxicol. Intraperitoneal gardiquimod protects against hepatotoxicity through inhibition of oxidative stress and inflammation in mice with sepsis

[3] Bo Jia, et al. Mol Biol Rep. Gardiquimod inhibits the expression of calcium-induced differentiation markers in HaCaT cells

[4] Andreas Weber, et al. Int Immunopharmacol. Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod™

[5] Maarten Buitendijk, et al. AIDS Res Hum Retroviruses. Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells

Related TLR Products
Kdo2-Lipid A ammonium

Kdo2-Lipid A ammonium is a chemically defined lipopolysaccharide (LPS) with endotoxic activity equivalent to LPS.Kdo2-Lipid A ammonium is highly selective for TLR4 and stimulates the release of TNF and PGE2.

PSMα3

PSMα3 is a peptide for manipulating DCs to become tolerogenic for DC vaccination strategies.

Pam2CSK4

Pam2CSK4, a lipopeptide, is a TLR6-independent TLR2 ligand and agonist.

MAPK-IN-1

MAPK-IN-1 is a MAPK signaling pathway inhibitor.

Cobitolimod

Cobitolimod is a first-of-its-kind (first-in-class), synthetic oligodeoxynucleotide (ODN) containing unmethylated CpG motifs that activates TLR9 in specific cells, including intestinal T and B lymphocytes as well as antigen-presenting cells (APCs), and can be used in studies related to inflammatory bowel disease (IBD).

  Catalog
Abmole Inhibitor Catalog




Keywords: Gardiquimod diTFA  supplier, TLR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.